Mannatide Combined With CAPOX and Tislelizumab for Advanced Gastric Cancer.
Mannatide Combined With CAPOX and Tislelizumab for Advanced Gastric Cancer.
Not yet recruiting · NCT07655661 · Registry updated 2026-06-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Mannatide Combined With CAPOX and Tislelizumab for Advanced Gastric Cancer. | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric adenocarcinoma, gastric neoplasm, gastroesophageal junction adenocarcinoma, neoplasm, stomach disorder | Not yet recruiting | Phase 2 | 2026-06-18 | NCT07655661 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ming Liu | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| West China Hospital of Sichuan University | Chengdu | China | 117 |